Cargando…

The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders

Peroxisome proliferator-activated receptors (PPARs) are ligand-modulated nuclear receptors that play pivotal roles in nutrient sensing, metabolism, and lipid-related processes. Correct control of their target genes requires tight regulation of the expression of different PPAR isoforms in each tissue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Porcuna, Jesús, Mínguez-Martínez, Jorge, Ricote, Mercedes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508752/ https://www.ncbi.nlm.nih.gov/pubmed/34638914 http://dx.doi.org/10.3390/ijms221910573

Ejemplares similares

PPARs in the Renal Regulation of Systemic Blood Pressure
por: Rőszer, Tamás, et al.
Publicado: (2010)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
por: Lemkul, Justin A., et al.
Publicado: (2015)

PPARα/γ-Independent Effects of PPARα/γ Ligands on Cysteinyl Leukotriene Production in Mast Cells
por: Yamashita, Masamichi
Publicado: (2008)

The CD36-PPARγ Pathway in Metabolic Disorders
por: Maréchal, Loïze, et al.
Publicado: (2018)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ
por: Zhu, Ya-Di, et al.
Publicado: (2021)

PPARγ and PPARα synergize to induce robust browning of white fat in vivo
por: Kroon, Tobias, et al.
Publicado: (2020)

Revisiting PPARγ as a target for the treatment of metabolic disorders
por: Choi, Sun-Sil, et al.
Publicado: (2014)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

Transcriptional Regulation of Human and Rat Hepatic Lipid Metabolism by the Grapefruit Flavonoid Naringenin: Role of PPARα, PPARγ and LXRα
por: Goldwasser, Jonathan, et al.
Publicado: (2010)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

PPAR α and PPAR γ Polymorphisms as risk factors for Dyslipidemia in a Chinese han population
por: Gu, Shu-Jun, et al.
Publicado: (2014)

MDG-1, a Potential Regulator of PPARα and PPARγ, Ameliorates Dyslipidemia in Mice
por: Wang, Xu, et al.
Publicado: (2017)

PPARα-mediated peroxisome induction compensates PPARγ-deficiency in bronchiolar club cells
por: Karnati, Srikanth, et al.
Publicado: (2018)

PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective
por: Orozco Morales, M. Lizeth, et al.
Publicado: (2021)

Transcriptional and epigenetic regulation of PPARγ expression during adipogenesis
por: Lee, Ji-Eun, et al.
Publicado: (2014)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery Disease
por: Song, Yongyan, et al.
Publicado: (2022)

Comparative Molecular Profiling of the PPARα/γ Activator Aleglitazar: PPAR Selectivity, Activity and Interaction with Cofactors
por: Dietz, Michel, et al.
Publicado: (2012)

β-arrestin-1 contributes to brown fat function and directly interacts with PPARα and PPARγ
por: Wang, Congcong, et al.
Publicado: (2016)

PPARγ and MEK Interactions in Cancer
por: Burgermeister, Elke, et al.
Publicado: (2008)

PPARγ and Proline Oxidase in Cancer
por: Phang, James M., et al.
Publicado: (2008)

Microsecond MD Simulations to Explore the Structural and Energetic Differences between the Human RXRα-PPARγ vs. RXRα-PPARγ-DNA
por: Azam, Faizul, et al.
Publicado: (2022)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Peroxisome proliferator-activated receptors (PPARα, PPARγ and PPARβ/δ) gene expression profile on ram spermatozoa and their relation to the sperm motility
por: Kadivar, Ali, et al.
Publicado: (2016)

PPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice
por: Xi, Zheng-Xiong, et al.
Publicado: (2023)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

Solution Structures of PPARγ2/RXRα Complexes
por: Osz, Judit, et al.
Publicado: (2012)

The regulation of catalase activity by PPAR γ is affected by α-synuclein
por: Yakunin, Eugenia, et al.
Publicado: (2014)

PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
por: Corona, Juan Carlos, et al.
Publicado: (2014)

Dual PPAR α/γ Agonists: Continuing Cardiac Concerns
por: Balachandran, Karthik
Publicado: (2019)

PGC-1α Protects against Hepatic Ischemia Reperfusion Injury by Activating PPARα and PPARγ and Regulating ROS Production
por: Wang, Chaoqun, et al.
Publicado: (2021)

PPARγ Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us?
por: da Rocha Junior, Laurindo Ferreira, et al.
Publicado: (2013)

A Role for the PPARγ in Cancer Therapy
por: Campbell, Moray J., et al.
Publicado: (2008)

Clinical Use of PPARγ Ligands in Cancer
por: Hatton, Jennifer L., et al.
Publicado: (2008)

PPARγ, PTEN, and the Fight against Cancer
por: Teresi, Rosemary E., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_03fgd9lcngc249jrfo1llphp86